These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16754296)

  • 21. The role of electrophoresis in disease biomarker discovery.
    Issaq HJ; Veenstra TD
    Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular methods for the diagnosis of cancer.
    Cairns P; Sidransky D
    Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
    [No Abstract]   [Full Text] [Related]  

  • 23. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor markers. Key pieces to your cancer patient's clinical picture.
    Ostchega Y; Culnane M
    Nursing; 1985 Sep; 15(9):48-51. PubMed ID: 2410836
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
    Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
    J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microchip-based multiplex electro-immunosensing system for the detection of cancer biomarkers.
    Ko YJ; Maeng JH; Ahn Y; Hwang SY; Cho NG; Lee SH
    Electrophoresis; 2008 Aug; 29(16):3466-76. PubMed ID: 18651704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of a seminoma cell-line (S2).
    von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C
    Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tumor markers of childhood cancer].
    Shioda Y; Kumagai MA
    Gan To Kagaku Ryoho; 2005 May; 32(5):699-704. PubMed ID: 15918577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for heterogeneous enzyme immunoassays for tumor markers.
    King WJ; Tomita JT; Dowell BL; Delfert DM
    Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
    [No Abstract]   [Full Text] [Related]  

  • 32. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
    Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.
    Drukier AK; Ossetrova N; Schors E; Krasik G; Grigoriev I; Koenig C; Sulkowski M; Holcman J; Brown LR; Tomaszewski JE; Schnall MD; Sainsbury R; Lokshin AE; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):1906-15. PubMed ID: 16889412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical technologies for the diagnosis of prostate cancer.
    Fitzsimons NJ; Sun L; Moul JW
    Expert Rev Med Devices; 2007 Mar; 4(2):227-39. PubMed ID: 17359227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.